Annals of Neurology · 1995 · 89 citations · 34 references
MedicineGeneticsNeurologyDementiaNeurodegenerationNeurogeneticsAlzheimer DiseaseDementia GeneticsDementia Risk FactorsNeurodegenerative Disease GeneticsNeurodegenerative DiseasesParkinson Disease DementiaAlzheimer Disease DementiaApoe GeneticsApolipoprotein E Genotype RiskApolipoprotein E VariantsDementia Risk LociGenetic Epidemiology Of DementiaNeurodegenerative Genetics
The apolipoprotein E gene (Apo E) type 4 allele is a genetic risk factor influencing the development and age of onset of Alzheimer's disease. Because Parkinson's disease shares many characteristics of Alzheimer's disease, we studied the frequencies of Apo E genotypes in a cohort of 52 Parkinson's disease patients with dementia and 61 patients without dementia. Dementia was determined per National Institute of Neurological and Communicative Disorders and Stroke criteria and Mattis Dementia Rating Scale (DRS) < 126. Normal cognition was defined as DRS > 132. Apo E genotype and allele frequencies did not differ between demented and nondemented parkinsonian patients. Neither group's genotype and allele frequencies differed from that of a nondemented population of 78 controls. We conclude that the Apo E epsilon 4 allele influences neither the development of Parkinson's disease nor the dementia associated with Parkinson's disease.
34
Warren J. Strittmatter, Ann M. Saunders, D. E. Schmechel et al. · Proceedings of the National Academy of Sciences · 1993 · 4.3K citations · Full text
Life Sciences, Genetics, Neurology +17
D. E. Schmechel, Ann M. Saunders, Warren J. Strittmatter et al. · Proceedings of the National Academy of Sciences · 1993 · 1.5K citations · Full text